Search

Your search keyword '"Lesche, Ralf"' showing total 306 results

Search Constraints

Start Over You searched for: Author "Lesche, Ralf" Remove constraint Author: "Lesche, Ralf"
306 results on '"Lesche, Ralf"'

Search Results

2. Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling

6. Identification of Small Molecules that Modulate Mutant p53 Condensation

7. Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis

8. Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy

9. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

10. Novel YAP1/TAZ pathway inhibitors identified through phenotypic screening with potent anti-tumor activity via blockade of GGTase-I / Rho-GTPase signaling

11. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies

15. Abstract 6089: Identification of novel YAP/TAZ pathway regulators in the triple-negative breast cancer cell line MDA-MB231 using single-cell CRISPR screening

16. Supplemental Tables S1-3 from Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance

18. Data from Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance

19. Supplementary Methods from Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance

22. Supplementary Table S4 from Identification and Validation of Colorectal Neoplasia–Specific Methylation Markers for Accurate Classification of Disease

24. Figures S1-S5 from Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance

25. Supplementary Data from DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy

26. Data from DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy

31. Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition.

33. Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A

35. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

36. A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome.

37. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases.

39. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients

41. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

42. RNA-Sequencing of Long-Term Label-Retaining Colon Cancer Stem Cells Identifies Novel Regulators of Quiescence

43. Identification of a Nervous System Gene Expression Signature in Colon Cancer Stem Cells Reveals a Role for Neural Crest RegulatorsEGR2andSOX2in Tumorigenesis

44. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients

45. An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases

46. DNA Methylation Analysis

49. Contributors

Catalog

Books, media, physical & digital resources